BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 1285413)

  • 1. Immunity, microbial pathogenesis, and immunophilins: finding the keys, now where are the locks?
    High KP; Handschumacher RE
    Infect Agents Dis; 1992 Jun; 1(3):121-35. PubMed ID: 1285413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclosporin A, FK506, and rapamycin: binding to immunophilins and biological action.
    Bierer BE
    Chem Immunol; 1994; 59():128-55. PubMed ID: 7524531
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunophilins in protein folding and immunosuppression.
    Fruman DA; Burakoff SJ; Bierer BE
    FASEB J; 1994 Apr; 8(6):391-400. PubMed ID: 7513288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophilins and the nervous system.
    Snyder SH; Sabatini DM
    Nat Med; 1995 Jan; 1(1):32-7. PubMed ID: 7584950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia.
    Sharkey J; Butcher SP
    Nature; 1994 Sep; 371(6495):336-9. PubMed ID: 7522303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry and biology of the immunophilins and their immunosuppressive ligands.
    Schreiber SL
    Science; 1991 Jan; 251(4991):283-7. PubMed ID: 1702904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of immunosuppressive agents.
    Borel JF; Baumann G
    Bull Mem Acad R Med Belg; 1994; 149(1-2):97-101; discussion 101-3. PubMed ID: 7531051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proline isomerases at the crossroads of protein folding, signal transduction, and immunosuppression.
    Heitman J; Movva NR; Hall MN
    New Biol; 1992 May; 4(5):448-60. PubMed ID: 1515410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophilins, ligands, and the control of signal transduction.
    Schreiber SL; Crabtree GR
    Harvey Lect; 1995-1996; 91():99-114. PubMed ID: 9127988
    [No Abstract]   [Full Text] [Related]  

  • 10. The human erythrocyte membrane contains a novel 12-kDa inositolphosphate-binding protein that is an immunophilin.
    Cunningham EB
    Biochem Biophys Res Commun; 1995 Oct; 215(1):212-8. PubMed ID: 7575593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural roles of immunophilins and their ligands.
    Sabatini DM; Lai MM; Snyder SH
    Mol Neurobiol; 1997 Oct; 15(2):223-39. PubMed ID: 9396011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The antiparasite effects of cyclosporin A: possible drug targets and clinical applications.
    Bell A; Roberts HC; Chappell LH
    Gen Pharmacol; 1996 Sep; 27(6):963-71. PubMed ID: 8909976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biology of cyclosporin A and FK506.
    Bierer BE
    Prog Clin Biol Res; 1994; 390():203-23. PubMed ID: 7536944
    [No Abstract]   [Full Text] [Related]  

  • 14. A nonimmunosuppressive triene-modified rapamycin analog is a potent inhibitor of peptidyl prolyl cis-trans isomerase.
    Ocain TD; Longhi D; Steffan RJ; Caccese RG; Sehgal SN
    Biochem Biophys Res Commun; 1993 May; 192(3):1340-6. PubMed ID: 7685167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclosporin A, FK-506, and rapamycin: pharmacologic probes of lymphocyte signal transduction.
    Sigal NH; Dumont FJ
    Annu Rev Immunol; 1992; 10():519-60. PubMed ID: 1375473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunophilins: structure-function relationship and possible role in microbial pathogenicity.
    Hacker J; Fischer G
    Mol Microbiol; 1993 Nov; 10(3):445-56. PubMed ID: 7526121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nephrotoxicity of immunosuppressants in rats: comparison of macrolides with cyclosporin.
    Ryffel B; Weber E; Mihatsch MJ
    Exp Nephrol; 1994; 2(6):324-33. PubMed ID: 7532090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of T-cell signaling pathways by immunophilin drug complexes: are side effects inherent to immunosuppressive properties?
    Schreier MH; Baumann G; Zenke G
    Transplant Proc; 1993 Feb; 25(1 Pt 1):502-7. PubMed ID: 7679818
    [No Abstract]   [Full Text] [Related]  

  • 19. Is FKBP involved in the immunosuppressive and/or toxic mechanism of action of FK 506?
    Sigal NH; Dumont FJ; Siekierka JJ; Wiederrecht G; Parent SA; Brizuela L
    Transplant Proc; 1991 Dec; 23(6):2846-9. PubMed ID: 1721295
    [No Abstract]   [Full Text] [Related]  

  • 20. Modes of action of FK506, cyclosporin A, and rapamycin.
    Morris R
    Transplant Proc; 1994 Dec; 26(6):3272-5. PubMed ID: 7527964
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.